Multicomponent Therapy for Age-related Skin Stem Cell Deficiency
治疗与年龄相关的皮肤干细胞缺乏症的多成分疗法
基本信息
- 批准号:10707346
- 负责人:
- 金额:$ 223.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAgeAgingAnimalsAppearanceAtrophicAuthorization documentationBioinformaticsBiologyCOVID-19Cell CommunicationCellsCellular Metabolic ProcessChronicClinicalCombined Modality TherapyCutaneousDNADataDefectDermalDetectionDevelopmentElderlyEpidemicEpigenetic ProcessEvaluationEvolutionFunctional disorderGenerationsGenomicsGoalsHealthHumanHuman ResourcesIndividualInstitutionLeftMaintenanceMapsMembrane Transport ProteinsMetabolicMethodsNatural regenerationNormal tissue morphologyPathologyPathway interactionsPhenotypePhysiologicalPopulationPremature aging syndromePreventionProductivityReceptor CellRecordsRegenerative responseRegulationResearchResearch PersonnelResearch ProposalsResourcesRoleSeveritiesSkinSkin injurySocietiesSourceStem cell pluripotencyTechnologyTherapeuticTherapeutically TargetableThinnessUnited StatesYouthage relatedagedauthoritybiomarker discoverychronic ulcercofactorcombinatorialcomorbiditydecubitus ulcerdesigneditorialepidermal stem cellepigenomicshealinghealth care service utilizationin vivometabolomicsmiddle agemouse modelmultidisciplinaryneglectnovelnovel strategiespluripotencypsychosocialreceptorregeneration potentialregenerativeregenerative cellrepairedresponserestorationskin damageskin ulcerstem cell biologystem cell fatestem cell functionstem cellssuccesssynergismtargeted treatmenttissue injurytissue repairwoundwound healingwound treatment
项目摘要
SUMMARY
Chronic ulcers, defined as wounds that fail to heal within a three-month period, are associated with age-related
dysfunction in skin stem cells that not only has potential to blunt tissue repair, but also accounts for skin fragility,
atrophy, and the "aging phenotype" that itself has clinical as well as psychosocial implications. Non-healing
ulcers in aging individuals represent a multibillion dollar burden in the United States and to society globally, both
through utilization of health care resources as well as through reduction in productivity. Nonetheless, it is
recognized that "the basic biology and the influence of age-associated changes on wound healing are poorly
understood, and there are numerous research questions still to be answered". To address this important issue,
we have 1) assembled a highly collaborative and multidisciplinary team of investigators with established track
records in skin pathology, regenerative and stem cell biology, wound healing, bioinformatics, and the
pathobiology of aging; 2) leveraged the resources of seven Harvard Institutions to develop a unified and state-
of-the-art approach to decipher the role skin stem cell deficiency in age-related defective wound healing; and 3)
generated data-based hypotheses and identified inter-project synergies that will maximize productivity and
translational focus. Our fundamental hypothesis is that identification and interrogation of three major, inter-
related, and therapeutically targetable/reprogrammable pathways relevant to age-related skin stem cell
dysfunction, a) metabolic, b) epigenetic, and c) membrane transporter/receptor, will pave the way for
combinatorial (multicomponent) therapies necessary for more robust healing and regenerative responses to skin
injury. We will pursue this goal through six strategies that have been developed by the key personnel of this
PPG: 1) discovery of biomarkers for epidermal and dermal stem cell identification and manipulation; 2)
determination of metabolic regulators required for epidermal progenitor activity and maintenance; 3) identification
of novel epigenetic pathways that govern skin stem cell function and vitality; 4) development and evaluation of
unique murine models that permit study of human wound healing in vivo; 5) deployment of lineage tracking
technologies that facilitate detection of experimentally-manipulated stem cell fate in healing wounds; and 6)
generation of new animal strains and for epigenomic induction of premature aging and methods for genomic
restoration of stem cell youth and pluripotency. Our overall aims seek to answer the following questions: 1) How
can one map the key metabolomic, epigenetic, and cell receptor stem cell pathways that drive age-related wound
healing dysfunction?; 2) What are the therapeutically-accessible nodes for stem cell-directed multicomponent
combinatorial targeting within these pathways?; and 3) What are the agents that likely will affect restoration of
robust and regenerative stem cell-driven responses to wound healing and support physiologic cutaneous
maintenance and health? Success in this endeavor could be transformative in understanding how aged stem
cells may be restored to functional vigor implicit to normal tissue integrity and regenerative potential.
总结
慢性溃疡,定义为伤口在三个月内未能愈合,与年龄相关的
皮肤干细胞的功能障碍不仅有可能使组织修复变钝,而且还导致皮肤脆弱,
萎缩,以及本身具有临床和心理社会影响的“衰老表型”。不愈合
老年人的溃疡在美国和全球社会都是数十亿美元的负担,
通过利用卫生保健资源以及通过降低生产率。尽管如此,
认识到“基础生物学和年龄相关变化对伤口愈合的影响很差,
我们已经了解,还有许多研究问题有待回答”。为了解决这一重要问题,
我们已经1)组建了一个高度合作和多学科的调查团队,
记录在皮肤病理学,再生和干细胞生物学,伤口愈合,生物信息学,
衰老的病理生物学; 2)利用七个哈佛机构的资源来开发一个统一的国家-
最先进的方法来破译皮肤干细胞缺乏在年龄相关的缺陷性伤口愈合中的作用;以及3)
产生了基于数据的假设,并确定了将最大限度地提高生产力的项目间协同作用,
翻译焦点我们的基本假设是,识别和审讯三个主要的,相互-
与年龄相关的皮肤干细胞相关的治疗靶向/可重编程途径
功能障碍,a)代谢,B)表观遗传,和c)膜转运蛋白/受体,将铺平道路,
组合(多组分)疗法对于皮肤更稳健的愈合和再生反应是必要的
损伤我们将通过六项战略来实现这一目标,这些战略是由本组织的主要人员制定的。
PPG:1)发现用于表皮和真皮干细胞鉴定和操作的生物标志物; 2)
确定表皮祖细胞活性和维持所需的代谢调节剂; 3)鉴定
控制皮肤干细胞功能和活力的新型表观遗传途径; 4)开发和评估
允许在体内研究人类伤口愈合的独特鼠模型; 5)谱系追踪的部署
促进检测愈合伤口中实验操作的干细胞命运的技术;以及6)
产生新的动物品系和用于表观基因组诱导过早衰老的方法
恢复干细胞年轻和多能性。我们的总体目标是寻求回答以下问题:1)如何
能否绘制出导致年龄相关创伤的关键代谢组学、表观遗传学和细胞受体干细胞通路
愈合功能障碍?2)干细胞定向多组分治疗的可及节点是什么?
在这些通路中的组合靶向?和3)哪些因素可能会影响恢复
强大的和再生的干细胞驱动的反应,伤口愈合和支持生理皮肤
维护和健康?这项奋进的成功可能会改变人们对老化干细胞
细胞可以恢复到正常组织完整性和再生潜力所隐含的功能活力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Markus H. Frank其他文献
Méthodes diagnostiques et thérapeutiques se rapportant à des cellules souches cancéreuses
癌症细胞的诊断和治疗方法
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
Markus H. Frank;Natasha Y. Frank - 通讯作者:
Natasha Y. Frank
Utilisation de polynucléotides de la subtilisine (RNR9) pour obtenir une résistance à un pathogène dans les plantes
利用枯草杆菌多核苷酸 (RNR9) 获得植物病原体的抗性
- DOI:
- 发表时间:
2008 - 期刊:
- 影响因子:0
- 作者:
Markus H. Frank;P. Schweizer;Dimitar Douchkov - 通讯作者:
Dimitar Douchkov
Caveolin 1 and 2 enhance the proliferative capacity of BCAM-positive corneal progenitors
- DOI:
10.1038/s41598-024-81283-4 - 发表时间:
2025-02-24 - 期刊:
- 影响因子:3.900
- 作者:
Yuzuru Sasamoto;Shoko Kiritoshi;Catherine A. A. Lee;Yoshiko Fukuda;Gabrielle Martin;Bruce R. Ksander;Markus H. Frank;Natasha Y. Frank - 通讯作者:
Natasha Y. Frank
Procédé d'augmentation de la résistance aux champignons dans les plantes
植物中香菇抵抗力的增强过程
- DOI:
- 发表时间:
2007 - 期刊:
- 影响因子:0
- 作者:
Holger Schultheiss;Markus H. Frank;Caroline Höfle - 通讯作者:
Caroline Höfle
Angiogenin Released from ABCB5sup+/sup Stromal Precursors Improves Healing of Diabetic Wounds by Promoting Angiogenesis
ABCB5 阳性基质前体细胞释放的血管生成素通过促进血管生成改善糖尿病伤口愈合
- DOI:
10.1016/j.jid.2021.10.026 - 发表时间:
2022-06-01 - 期刊:
- 影响因子:5.700
- 作者:
Karmveer Singh;Pallab Maity;Albert Kallon Koroma;Abhijit Basu;Rajeev Kumar Pandey;Seppe Vander Beken;Philipp Haas;Linda Krug;Adelheid Hainzl;Anca Sindrilaru;Christiane Pfeiffer;Meinhard Wlaschek;Natasha Y. Frank;Markus H. Frank;Christoph Ganss;András Bánvölgyi;Norbert Wikonkál;Sabine Eming;Irena Pastar;Marjana Tomic-Canic;Karin Scharffetter-Kochanek - 通讯作者:
Karin Scharffetter-Kochanek
Markus H. Frank的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Markus H. Frank', 18)}}的其他基金
Multicomponent Therapy for Age-related Skin Stem Cell Deficiency
治疗与年龄相关的皮肤干细胞缺乏症的多成分疗法
- 批准号:
10494654 - 财政年份:2022
- 资助金额:
$ 223.18万 - 项目类别:
Stem Cell Integral Membrane Transporter ABCB5 and Dermal Regeneration
干细胞整体膜转运蛋白 ABCB5 和真皮再生
- 批准号:
10494660 - 财政年份:2022
- 资助金额:
$ 223.18万 - 项目类别:
Stem Cell Integral Membrane Transporter ABCB5 and Dermal Regeneration
干细胞整体膜转运蛋白 ABCB5 和真皮再生
- 批准号:
10707397 - 财政年份:2022
- 资助金额:
$ 223.18万 - 项目类别:
Immunology of human malignant melanoma initiating cells
人类恶性黑色素瘤起始细胞的免疫学
- 批准号:
8532856 - 财政年份:2012
- 资助金额:
$ 223.18万 - 项目类别:
Immunology of human malignant melanoma initiating cells
人类恶性黑色素瘤起始细胞的免疫学
- 批准号:
8239174 - 财政年份:2012
- 资助金额:
$ 223.18万 - 项目类别:
Immunology of human malignant melanoma initiating cells
人类恶性黑色素瘤起始细胞的免疫学
- 批准号:
8685190 - 财政年份:2012
- 资助金额:
$ 223.18万 - 项目类别:
Immunology of human malignant melanoma initiating cells
人类恶性黑色素瘤起始细胞的免疫学
- 批准号:
9112874 - 财政年份:2012
- 资助金额:
$ 223.18万 - 项目类别:
Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression
黑色素瘤干细胞、血管生成和肿瘤进展
- 批准号:
8307737 - 财政年份:2008
- 资助金额:
$ 223.18万 - 项目类别:
Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression
黑色素瘤干细胞、血管生成和肿瘤进展
- 批准号:
8109826 - 财政年份:2008
- 资助金额:
$ 223.18万 - 项目类别:
Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression
黑色素瘤干细胞、血管生成和肿瘤进展
- 批准号:
7692241 - 财政年份:2008
- 资助金额:
$ 223.18万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 223.18万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 223.18万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 223.18万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 223.18万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 223.18万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 223.18万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 223.18万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 223.18万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 223.18万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 223.18万 - 项目类别:
Research Grant














{{item.name}}会员




